We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

111 hedge funds and large institutions have $266M invested in GenMark Diagnostics, Inc in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 28

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 110 → 111 (+1)

17% less capital invested

Capital invested by funds: $320M → $266M (-$53.9M)

Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
49
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.79M
2
NIM
Needham Investment Management
New York
+$3.01M
3
Bank of America
Bank of America
North Carolina
+$2.35M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.04M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.89M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$2.49M
3
Millennium Management
Millennium Management
New York
-$1.86M
4
MAG
Millrace Asset Group
Pennsylvania
-$1.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$41.9M +$514K +93,158 +1%
CCM
2
Cadian Capital Management
New York
$26.5M -$691K -125,351 -2%
Morgan Stanley
3
Morgan Stanley
New York
$24.8M +$5.79M +1,049,280 +26%
BlackRock
4
BlackRock
New York
$20.6M +$309K +55,948 +1%
CC
5
Casdin Capital
New York
$16.2M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$15.2M +$2.04M +369,323 +13%
BG
7
Bellevue Group
Switzerland
$11.7M +$960K +173,989 +8%
HighTower Advisors
8
HighTower Advisors
Illinois
$10.9M -$402K -72,811 -3%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$10.2M -$4.89M -886,572 -30%
Bank of America
10
Bank of America
North Carolina
$10.1M +$2.35M +425,891 +25%
State Street
11
State Street
Massachusetts
$5.28M -$35.9K -6,517 -0.6%
PCM
12
Penn Capital Management
Pennsylvania
$4.7M +$1.86M +336,979 +53%
JP Morgan Chase
13
JP Morgan Chase
New York
$4.27M -$627K -113,584 -11%
NIM
14
Needham Investment Management
New York
$3.82M +$3.01M +545,000 +218%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.66M +$110K +19,953 +3%
Northern Trust
16
Northern Trust
Illinois
$3.65M +$13.2K +2,386 +0.3%
Renaissance Technologies
17
Renaissance Technologies
New York
$3.44M +$879K +159,400 +29%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$3.06M +$1.4M +254,433 +66%
N
19
Nuveen
North Carolina
$2.91M +$689K +124,900 +26%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$2.89M +$290K +52,490 +10%
GIP
21
Granite Investment Partners
California
$2.83M +$936K +169,640 +40%
Goldman Sachs
22
Goldman Sachs
New York
$2.38M -$284K -51,516 -9%
PHP
23
Parkman Healthcare Partners
Connecticut
$2.02M +$2.32M +420,000 New
State of New Jersey Common Pension Fund D
24
State of New Jersey Common Pension Fund D
New Jersey
$1.95M +$270K +48,883 +14%
Point72 Asset Management
25
Point72 Asset Management
Connecticut
$1.71M +$1.96M +355,680 New
1
2 3 4 5

GNMK Hedge Fund Activity: Q4 2019 in Review

111 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2019, worth a combined $266M — down 17% from $320M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 49 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.79M. The largest seller was T. Rowe Price Associates, cutting an estimated $4.89M.

  • 111 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2019, up from 110 in Q3 2019.
  • Funds reported $266M of GenMark Diagnostics, Inc stock for Q4 2019, down 17% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q4 2019 and 9 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2019 was Morgan Stanley, an estimated $5.79M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2019 was T. Rowe Price Associates, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.